Mechanistically, RBM4 antagonizes SRSF1 and upregulates the expression of the pro-apoptotic Bcl-xS isoform, thus acting as a tumor suppressor (Wang et al., 2014). This evidence concerns the gene BCL2L1 and neoplasm.